Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
Timothy Juday,1 Todd Correll,1 Ayanna Anene,2 Michael S Broder,2 Jesse Ortendahl,2 Tanya Bentley21Bristol-Myers Squibb, Plainsboro, NJ, USA; 2Partnership for Health Analytic Research LLC, Beverly Hills, CA, USABackground: February 2013 US treatment guidelines recommend the once-daily tablet of efavi...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Libro |
| Pubblicazione: |
Dove Medical Press,
2013-09-01T00:00:00Z.
|
| Soggetti: | |
| Accesso online: | Connect to this object online. |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
| Collocazione: |
A1234.567 |
|---|---|
| Copia 1 | Disponibile |